{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:18:36Z","timestamp":1707524316288},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,2]]},"DOI":"10.7759\/cureus.15401","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T22:50:33Z","timestamp":1622674233000},"source":"Crossref","is-referenced-by-count":0,"title":["Exacerbation of Galli-Galli Disease Following Dialysis Treatment: A Case Report and Review of Aggravating Factors"],"prefix":"10.7759","author":[{"given":"Tejas P","family":"Joshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Shaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Tschen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000001467","article-title":"Atypical disseminated variant of Galli-Galli disease: a review of the literature","volume":"42","author":"Yang A","year":"2020","unstructured":"Yang A, Cheung K, Kossard S, Murrell DF. Atypical disseminated variant of Galli-Galli disease: a review of the literature. Am J Dermatopathol. 2020, 42:484-90. 10.1097\/DAD.0000000000001467","journal-title":"Am J Dermatopathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.05.041","article-title":"Galli-Galli disease: a case report with review of the literature","volume":"58","author":"Gilchrist H","year":"2008","unstructured":"Gilchrist H, Jackson S, Morse L, Nicotri T, Nesbitt LT. Galli-Galli disease: a case report with review of the literature. J Am Acad Dermatol. 2008, 58:299-302. 10.1016\/j.jaad.2007.05.041","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15385","article-title":"Dowling-Degos disease: a review","author":"Stephan C","year":"2020","unstructured":"Stephan C, Kurban M, Abbas O. Dowling-Degos disease: a review. Int J Dermatol. 2020, 10.1111\/ijd.15385","journal-title":"Int J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12813","article-title":"Heterozygous frameshift mutation in keratin 5 in a family with Galli-Galli disease","volume":"170","author":"Reisenauer AK","year":"2014","unstructured":"Reisenauer AK, Wordingham SV, York J, Kokkonen EW, Mclean WH, Wilson NJ, Smith FJ. Heterozygous frameshift mutation in keratin 5 in a family with Galli-Galli disease. Br J Dermatol. 2014, 170:1362-5. 10.1111\/bjd.12813","journal-title":"Br J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09741.x","article-title":"Systematic mutation screening of KRT5 supports the hypothesis that Galli-Galli disease is a variant of Dowling-Degos disease","volume":"163","author":"Hanneken S","year":"2010","unstructured":"Hanneken S, R\u00fctten A, Pasternack SM, et al.. Systematic mutation screening of KRT5 supports the hypothesis that Galli-Galli disease is a variant of Dowling-Degos disease. Br J Dermatol. 2010, 163:197-200. 10.1111\/j.1365-2133.2010.09741.x","journal-title":"Br J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3119","article-title":"A Japanese case of Galli-Galli disease due to a previously unreported POGLUT1 mutation","volume":"99","author":"Kono M","year":"2019","unstructured":"Kono M, Sawada M, Nakazawa Y, Ogi T, Muro Y, Akiyama M. A Japanese case of Galli-Galli disease due to a previously unreported POGLUT1 mutation. Acta Derm Venereol. 2019, 99:458-9. 10.2340\/00015555-3119","journal-title":"Acta Derm Venereol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.02.042","article-title":"Acitretin therapy for Galli-Galli disease","volume":"6","author":"Rundle CW","year":"2020","unstructured":"Rundle CW, Ophaug S, Simpson EL. Acitretin therapy for Galli-Galli disease. JAAD Case Rep. 2020, 6:457-61. 10.1016\/j.jdcr.2020.02.042","journal-title":"JAAD Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.3","article-title":"Efficacy of ablative laser treatment in Galli-Galli disease","volume":"147","author":"Voth H","year":"2011","unstructured":"Voth H, Landsberg J, Reinhard G, Refke M, Betz RC, Bieber T, Wenzel J. Efficacy of ablative laser treatment in Galli-Galli disease. Arch Dermatol. 2011, 147:317-20. 10.1001\/archdermatol.2011.3","journal-title":"Arch Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13038","article-title":"A comparison of physical modalities in Galli-Galli disease: Erbium:YAG laser, Intense Pulsed Light and Electrofulguration","volume":"60","author":"Venning VL","year":"2019","unstructured":"Venning VL, Choi-Lombardi S, Wong XL, Cheung K, Sebaratnam DF. A comparison of physical modalities in Galli-Galli disease: Erbium:YAG laser, Intense Pulsed Light and Electrofulguration. Australas J Dermatol. 2019, 60:320-2. 10.1111\/ajd.13038","journal-title":"Australas J Dermatol"},{"key":"ref10","article-title":"[Genodermatosis in a pair of brothers: Dowling-Degos, Grover, Darier, Hailey-Hailey or Galli-Galli disease?]","volume":"33","author":"Bardach H","year":"1982","unstructured":"Bardach H, Gebhart W, Luger T. [Genodermatosis in a pair of brothers: Dowling-Degos, Grover, Darier, Hailey-Hailey or Galli-Galli disease?]. Hautarzt. 1982, 33:378-83.","journal-title":"Hautarzt"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2013.12.003","article-title":"Mutations in POGLUT1, encoding protein O-glucosyltransferase 1, cause autosomal-dominant Dowling-Degos disease","volume":"94","author":"Basmanav FB","year":"2014","unstructured":"Basmanav FB, Oprisoreanu AM, Pasternack SM, et al.. Mutations in POGLUT1, encoding protein O-glucosyltransferase 1, cause autosomal-dominant Dowling-Degos disease. Am J Hum Genet. 2014, 94:135-43. 10.1016\/j.ajhg.2013.12.003","journal-title":"Am J Hum Genet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14700","article-title":"Grover disease: review of subtypes with a focus on management options","volume":"59","author":"Aldana PC","year":"2020","unstructured":"Aldana PC, Khachemoune A. Grover disease: review of subtypes with a focus on management options. Int J Dermatol. 2020, 59:543-50. 10.1111\/ijd.14700","journal-title":"Int J Dermatol"},{"key":"ref13","article-title":"Galli-Galli disease presenting as a lentigo-like eruption: a further clinical feature in the wide spectrum of reticulate pigment disorders","volume":"25","author":"Paolino G","year":"2017","unstructured":"Paolino G, Donati M, Didona D, Panetta C, Donati P. Galli-Galli disease presenting as a lentigo-like eruption: a further clinical feature in the wide spectrum of reticulate pigment disorders. Acta Dermatovenerol Croat. 2017, 25:300-2.","journal-title":"Acta Dermatovenerol Croat"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12483","article-title":"Adverse effects of isotretinoin: a large, retrospective review","volume":"30","author":"Brzezinski P","year":"2017","unstructured":"Brzezinski P, Borowska K, Chiriac A, Smigielski J. Adverse effects of isotretinoin: a large, retrospective review. Dermatol Ther. 2017, 30:10.1111\/dth.12483","journal-title":"Dermatol Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-010-1936-5","article-title":"[Classical and atypical presentations of Galli-Galli disease]","volume":"61","author":"Mota R","year":"2010","unstructured":"Mota R, Reifenberger J, Hanneken S, M\u00fchlenst\u00e4dt E. [Classical and atypical presentations of Galli-Galli disease]. Hautarzt. 2010, 61:284-6. 10.1007\/s00105-010-1936-5","journal-title":"Hautarzt"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.5097","article-title":"Treatment of Grover disease with dupilumab","volume":"157","author":"Butler DC","year":"2021","unstructured":"Butler DC, Kollhoff A, Berger T. Treatment of Grover disease with dupilumab. JAMA Dermatol. 2021, 157:353-6. 10.1001\/jamadermatol.2020.5097","journal-title":"JAMA Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.12.031","article-title":"The uses of naltrexone in dermatologic conditions","volume":"80","author":"Lee B","year":"2019","unstructured":"Lee B, Elston DM. The uses of naltrexone in dermatologic conditions. J Am Acad Dermatol. 2019, 80:1746-52. 10.1016\/j.jaad.2018.12.031","journal-title":"J Am Acad Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-011-2222-x","article-title":"[Galli-Galli disease. Clinical and histopathological investigation using a case series of 18 patients]","volume":"62","author":"Hanneken S","year":"2011","unstructured":"Hanneken S, R\u00fctten A, Eigelshoven S, et al.. [Galli-Galli disease. Clinical and histopathological investigation using a case series of 18 patients]. Hautarzt. 2011, 62:842-51. 10.1007\/s00105-011-2222-x","journal-title":"Hautarzt"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.10.987","article-title":"The expanding spectrum of Galli-Galli disease","volume":"56","author":"El Shabrawi-Caelen L","year":"2007","unstructured":"El Shabrawi-Caelen L, R\u00fctten A, Kerl H. The expanding spectrum of Galli-Galli disease. J Am Acad Dermatol. 2007, 56:S86-91. 10.1016\/j.jaad.2006.10.987","journal-title":"J Am Acad Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.07.038","article-title":"Galli-Galli disease is an acantholytic variant of Dowling-Degos disease: additional genetic evidence in a German family","volume":"66","author":"Schmieder A","year":"2012","unstructured":"Schmieder A, Pasternack SM, Krahl D, Betz RC, Leverkus M. Galli-Galli disease is an acantholytic variant of Dowling-Degos disease: additional genetic evidence in a German family. J Am Acad Dermatol. 2012, 66:e250-1. 10.1016\/j.jaad.2011.07.038","journal-title":"J Am Acad Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/61396-exacerbation-of-galli-galli-disease-following-dialysis-treatment-a-case-report-and-review-of-aggravating-factors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:46Z","timestamp":1707507286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/61396-exacerbation-of-galli-galli-disease-following-dialysis-treatment-a-case-report-and-review-of-aggravating-factors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,2]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.15401","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,2]]}}}